相关实验视频

Updated: Jul 2, 2026

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

24.4K

在先进的NSCLC中KRAS G12C:流行率,共突变和测试

Tony Kiat Hon Lim1, Ferdinandos Skoulidis2, Keith M Kerr3

  • 1Division of Pathology, Singapore General Hospital, Singapore.

Lung cancer (Amsterdam, Netherlands)
|September 8, 2023
PubMed
概括

克拉斯G12C是非小细胞肺癌 (NSCLC) 的关键标. 对这种突变的测试对于指导治疗决策至关重要,特别是随着新的向治疗方法的可用性.

关键词:
适应性的 适应性的临床实践中的临床实践司机的基因认知发生在司机身上.现实世界的证据.这就是Sotorasib.有针对性的治疗.

更多相关视频

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.3K
Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.1K

相关概念视频

Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...